Physician profile
Edilgrale A Pecson
NPI 1285694851
$985.84
in general payments reported to CMS, 2019-2025
18 companies · $322 in 2025
The $322 reported for 2025 was more than what 86% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2020: $102 · 2021: $119 · 2022: $14.48 · 2023: $45.55 · 2024: $200 · 2025: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $567.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $567.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $180.42 | 2019-2025 | |
| Tris Pharma INC | $153.98 | 2020-2022 | |
| Corium, LLC | $130.16 | 2023-2025 | Azstarys |
| Abbvie INC. | $106.91 | 2019 | |
| Cranial Technologies, INC | $82.74 | 2019-2025 | Doc Band |
| Collegium Pharmaceutical, INC. | $63.12 | 2025 | Jornay Pm |
| Sanofi Pasteur INC. | $45.00 | 2025 | |
| Merck Sharp & Dohme LLC | $35.60 | 2025 | Vaxneuvance, Rotateq, Proquad |
| Glaxosmithkline, LLC. | $33.55 | 2019-2024 | Pediarix, Bexsero, Rotarix |
| Adlon Therapeutics L.P. | $28.50 | 2021 | |
| Kaleo, INC. | $21.66 | 2020 | |
| Alk-Abello, INC | $21.19 | 2025 | Neffy |
| Kowa Pharmaceuticals America, INC. | $15.25 | 2025 | Zoryve |
| Verrica Pharmaceuticals INC. | $14.97 | 2024 | Ycanth |
| Shire North American Group INC | $14.10 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cipher Pharmaceuticals US LLC | $13.99 | 2025 | Natroba, Spinosad |
| Ironshore Pharmaceuticals INC. | $12.89 | 2023 | Jornay Pm |
| Arbor Pharmaceuticals, INC. | $11.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edilgrale Pecson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.